Department of Health Distributes Third Shipment of Drug to Help Treat COVID-19 Patients in Hospitals


HARRISBURG, Pa. – The Department of Health distributed the third shipment of the investigational antiviral medication, remdesivir, to treat patients in the hospital with COVID-19. Yesterday, 8,928 doses of medication were sent to 81 hospitals. The medication was sent to the department by the federal government on Thursday, May 21 and shipped to these hospitals on Friday, May 22.

“The department is working to give our hospitals every opportunity to treat patients with COVID-19,” Secretary of Health Dr. Rachel Levine said. “It is important to note that there is limited information on the safety and effectiveness of using remdesivir to treat people in the hospital with COVID-19. However, it was shown in a clinical trial to shorten the recovery time in some people, which is why the Food and Drug Administration (FDA) has authorized the emergency use of the medication for treatment.”

The Department of Health first distributed 1,200 doses of the medication to 51 hospitals across Pennsylvania on Tuesday, May 12, and a second round of 7,938 doses were sent to 79 hospitals on Friday, May 15 and Monday, May 18. The hospitals that have received these shipments were determined based on the number of COVID-19 patients at the hospital over a recent seven-day period, and the severity of the illness of those patients based on whether they are on a ventilator. The department will continue to work with our federal partners to acquire more doses of this medication to serve more patients across Pennsylvania.

Remdesivir is given to a patient through an IV once per day for up to 10 days, depending on how critically ill the patient is. According to the FDA, remdesivir may help decrease the amount of coronavirus in your body, which may help you get better faster.

Symptoms of COVID-19 can include:

·       Fever

·       Cough

·       Shortness of breath or difficulty breathing

·       Diarrhea

·       Chills

·       Repeating shaking with chills

·       Muscle pain

·       Headache

·       Sore throat

·       New loss of taste or smell

Symptoms may appear in as few as two days or as long as 14 days after exposure. Reported illnesses have ranged from people with little to no symptoms to people being severely ill and dying.

As of 12:00 a.m., May 22, there were 66,258 positive cases of COVID-19 statewide in 67 counties and 4,984 confirmed deaths. Most of the patients hospitalized are 65 or older, and most of the deaths have occurred in patients 65 and older. There have been no pediatric deaths to date. More data is available here.

The Wolf Administration stresses the role Pennsylvanians play in helping to reduce the spread of COVID-19:

·       Wash your hands with soap and water for at least 20 seconds or use hand sanitizer if soap and water are not available.

·       Cover any coughs or sneezes with your elbow, not your hands.

·       Clean surfaces frequently.

·       Stay home to avoid spreading COVID-19, especially if you are unwell.

·       If you must go out for a life-sustaining reason, please wear a mask.

Updated Coronavirus Links: Press Releases, State Lab Photos, Graphics

·       Daily COVID-19 Report

·       Press releases regarding coronavirus

·       Latest information on the coronavirus

·       Photos of the state’s lab in Exton (for download and use)

·       Coronavirus and preparedness graphics (located at the bottom of the page)

·       Community preparedness and procedures materials

·       Map with the number of COVID-19 cases

All Pennsylvania residents are encouraged to sign up for AlertPA, a text notification system for health, weather, and other important alerts like COVID-19 updates from commonwealth agencies. Residents can sign up online at www.ready.pa.gov/BeInformed/Signup-For-Alerts


Copyright © 2024 EYT Media Group, Inc. All rights reserved. Any copying, redistribution or retransmission of the contents of this service without the express written consent of EYT Media Group, Inc. is expressly prohibited.

Comments are temporarily closed. A new and improved comments section will be added soon.